16:04 EST Sarepta (SRPT) files automatic mixed securities shelf
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SRPT:
- Sarepta Therapeutics’ Earnings Call Highlights Record Growth
- Sarepta Therapeutics Inc. Earnings Report: Did it Beat Expectations?
- Sarepta price target lowered to $210 from $217 at BofA
- Sarepta price target raised to $196 from $195 at Morgan Stanley
- Optimistic Buy Rating for Sarepta Therapeutics Driven by Elevidys Potential and Expanding Pipeline
